GASTROINTESTINAL HEMORRHAGE DUE TO SORAFENIB IN TWO PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

  • WATANABE Takao
    Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine.
  • HIASA Yoichi
    Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine.
  • HIROOKA Masashi
    Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine.
  • KISAKA Yoshiyasu
    Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine.
  • FURUKAWA Shinya
    Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine.
  • ABE Masanori
    Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine.
  • MURAKAMI Hidehiro
    Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine.
  • IKEDA Yoshio
    Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine.
  • MATSUURA Bunzo
    Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine.
  • ONJI Morikazu
    Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine.

Bibliographic Information

Other Title
  • ソラフェニブにより消化管出血を発症した進行肝細胞癌の2例

Search this article

Abstract

Two patients who had gastrointestinal hemorrhage due to Sorafenib are presented. In case 1, bloody stools occurred within 1 week after the Sorafenib treatment. The endoscopic findings revealed edematous and reddish changes in the duodenal mucosa. In case 2, bloody stools occurred 1 month after the Sorafenib treatment. Colonoscopic findings indicated similar mucosal change in the colon. The hemorrhagic points were difficult to detect in both cases. However, a quick improvement in the bloody stools after stopping Sorafenib intake suggested that the gastrointestinal hemorrhage was associated with Sorafenib treatment. The endoscopic mucosal findings in both cases would probably be characteristic of patients with gastrointestinal hemorrhage due to Sorafenib.

Journal

References(14)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top